Welcome to our dedicated page for Claritev SEC filings (Ticker: CTEV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Claritev Corporation filings document a healthcare technology, data and insights issuer with Class A common stock listed on the NYSE under CTEV. Its Form 8-K reports furnish operating results, financial-condition updates, investor presentations and Regulation FD materials tied to its analytics, AI and claims-based healthcare cost-management platform.
Proxy and annual-meeting filings cover board elections, auditor ratification, executive compensation, stockholder votes and amendments to the Claritev Corporation 2020 Omnibus Incentive Plan. Other material-event reports address share-repurchase authorization, capital-structure matters and governance transitions.
Claritev Corp’s latest Schedule 13G/A shows that investment firm Arini Capital Management Limited and related entities report beneficial ownership of 1,503,892 shares of Claritev common stock, representing 9.11% of the class based on 16,509,496 Class A ordinary shares.
Arini and affiliates report shared voting and dispositive power over these shares, with no sole voting or dispositive power. Within this group, Arini Credit Master Fund Limited holds 1,428,697 shares (8.65%), and Squarepoint Diversified Partners Fund 7 Limited holds 75,195 shares (0.46%). The filing states the securities are not held for the purpose of changing or influencing control of Claritev. Founder and CIO Hamza M. Lemssouguer, as sole owner of Arini Capital Management Holdings (Jersey) Limited, may be deemed a beneficial owner of the reported shares.
Claritev Corp executive Brock Albinson reported an equity award. On December 31, 2025, the SVP and Chief Accounting Officer received 1,169 shares of Class A common stock at $0 per share, reported as a grant of restricted stock units.
The restricted stock units vest in four equal installments of 25% each on December 31, 2026, 2027, 2028 and 2029. Following this grant, Albinson directly beneficially owns 3,994 Class A common shares.
Claritev Corporation furnished an investor slide presentation through a current report. Beginning on January 15, 2026, the company is making this presentation available on its website for investors, and it is also attached as Exhibit 99.1 to the report. The material is provided under Regulation FD, which is intended to ensure that all investors have equal access to important company information.
The company states that the presentation and related disclosure are being "furnished" rather than "filed," meaning they are not subject to certain liability provisions of the securities laws and are not automatically incorporated into other SEC filings unless specifically referenced.
Claritev Corporation reported that Dale White, its former Chief Executive Officer and Executive Chair and currently a director, will end his role as a strategic advisor to the company effective December 31, 2025. He has served in this advisory capacity since stepping down as Executive Chair on December 31, 2024. The company waived its contractual right to 30 days' written notice for ending the advisory role, and no additional compensation is due to Mr. White for this service. Mr. White will continue to serve on Claritev's board of directors.
Claritev Corp (CTEV) president, CEO, executive chair and director reported a personal-related purchase of Class A common stock. On 11/20/2025, the reporting person acquired 5,290 shares at a weighted average price of $47.2291 per share through the spouse's individual retirement account, which is reported as indirect ownership. After this transaction, indirect holdings in that account totaled 9,572 Class A shares, while direct ownership was reported as 243,058 Class A shares. The price range for the purchases on that date was from $47.0000 to $47.2300 per share.
Claritev Corp (CTEV) reported an insider stock purchase by its SVP and Chief Strategy Officer. On 11/17/2025, the executive bought 916 shares of Class A common stock in an open market transaction at a price of $38 per share, coded as a purchase ("P"). After this transaction, the executive beneficially owned a total of 65,325 shares, all held as a direct ownership position.
Claritev Corp (CTEV) reported a new large shareholder disclosure. Investment manager Arini Capital Management Limited and related entities report beneficial ownership of 1,261,250 Claritev common shares, representing 7.64% of the class. This ownership is calculated based on 10,000,000 Class A ordinary shares referenced from a prior Claritev Form 8-K.
The filing shows Arini Capital Management Limited, its U.S. affiliate, Arini Credit Master Fund Limited, Arini Capital Management Holdings (Jersey) Limited, and individual founder and CIO Hamza M. Lemssouguer as having shared voting and dispositive power over these shares, and no sole power. The certification states that the securities were not acquired and are not held for the purpose of changing or influencing control of Claritev, indicating a passive investment posture.
Claritev Corp (CTEV) executive vice president and chief digital officer reported buying additional company stock. On 11/17/2025, the officer purchased 9,600 shares of Class A common stock in an open-market transaction coded as a purchase at a price of $38.2499 per share. After this transaction, the executive beneficially owns 105,529 shares of Claritev Corp common stock, held directly.
Claritev Corp (CTEV) senior vice president and general counsel reported a small open-market purchase of company stock. On 11/17/2025, the officer acquired 625 shares of Class A common stock at a price of $38.8364 per share, according to a Form 4 filing. Following this transaction, the officer beneficially owns 25,028 shares of Claritev Class A common stock, held directly.
Claritev Corp (CTEV): Hellman & Friedman–affiliated reporting persons disclosed open‑market disposals of Class A common stock tied to an underwritten public offering on 11/12/2025. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions.
Reported transactions included, for example, a sale of 789,936 shares at $48.6675 per share and additional sales by affiliated funds on the same date. Following the transactions, each affiliated entity reported updated indirect beneficial holdings. The filing identifies the reporting persons as affiliated with Hellman & Friedman funds and indicates indirect ownership across multiple vehicles.